Ameritas Investment Partners, Inc. Day One Biopharmaceuticals, Inc. Transaction History
Ameritas Investment Partners, Inc.
- $2.98 Billion
- Q3 2024
A detailed history of Ameritas Investment Partners, Inc. transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 5,085 shares of DAWN stock, worth $66,155. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,085
Previous 5,085
-0.0%
Holding current value
$66,155
Previous $70,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding DAWN
# of Institutions
181Shares Held
84.2MCall Options Held
148KPut Options Held
218K-
Ra Capital Management, L.P. Boston, MA7.87MShares$102 Million1.53% of portfolio
-
Atlas Venture Life Science Advisors, LLC6.43MShares$83.7 Million11.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.89MShares$76.6 Million0.0% of portfolio
-
Braidwell LP Stamford, CT4.87MShares$63.4 Million1.92% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$59 Million0.0% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $956M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...